| Product Code: ETC9978997 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Veterinary Pharmacovigilance Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Veterinary Pharmacovigilance Market - Industry Life Cycle |
3.4 United States (US) Veterinary Pharmacovigilance Market - Porter's Five Forces |
3.5 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume Share, By Solution, 2021 & 2031F |
3.6 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
4 United States (US) Veterinary Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on animal health and welfare |
4.2.2 Rising demand for veterinary pharmaceuticals |
4.2.3 Stringent regulations and guidelines for veterinary drug safety |
4.3 Market Restraints |
4.3.1 Lack of awareness about pharmacovigilance in veterinary medicine |
4.3.2 Limited resources and infrastructure for monitoring adverse events in animals |
4.3.3 High costs associated with pharmacovigilance activities in the veterinary sector |
5 United States (US) Veterinary Pharmacovigilance Market Trends |
6 United States (US) Veterinary Pharmacovigilance Market, By Types |
6.1 United States (US) Veterinary Pharmacovigilance Market, By Solution |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Solution, 2021- 2031F |
6.1.3 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Software, 2021- 2031F |
6.1.4 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Veterinary Pharmacovigilance Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Biologics, 2021- 2031F |
6.2.3 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Anti-infectives, 2021- 2031F |
6.2.4 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Other Product, 2021- 2031F |
6.3 United States (US) Veterinary Pharmacovigilance Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By In-house, 2021- 2031F |
6.3.3 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Contract Outsourcing, 2021- 2031F |
6.4 United States (US) Veterinary Pharmacovigilance Market, By Animal Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Dogs, 2021- 2031F |
6.4.3 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Cats, 2021- 2031F |
6.4.4 United States (US) Veterinary Pharmacovigilance Market Revenues & Volume, By Other Animal Types, 2021- 2031F |
7 United States (US) Veterinary Pharmacovigilance Market Import-Export Trade Statistics |
7.1 United States (US) Veterinary Pharmacovigilance Market Export to Major Countries |
7.2 United States (US) Veterinary Pharmacovigilance Market Imports from Major Countries |
8 United States (US) Veterinary Pharmacovigilance Market Key Performance Indicators |
8.1 Number of reported adverse events in veterinary pharmacovigilance |
8.2 Compliance rate with veterinary drug safety regulations |
8.3 Adoption rate of pharmacovigilance practices in veterinary clinics |
8.4 Training and education programs on veterinary pharmacovigilance for professionals |
8.5 Number of veterinary drug recalls due to safety concerns |
9 United States (US) Veterinary Pharmacovigilance Market - Opportunity Assessment |
9.1 United States (US) Veterinary Pharmacovigilance Market Opportunity Assessment, By Solution, 2021 & 2031F |
9.2 United States (US) Veterinary Pharmacovigilance Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 United States (US) Veterinary Pharmacovigilance Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 United States (US) Veterinary Pharmacovigilance Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
10 United States (US) Veterinary Pharmacovigilance Market - Competitive Landscape |
10.1 United States (US) Veterinary Pharmacovigilance Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Veterinary Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here